Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Asparaginase Erwinia chrysanthemi is an asparagine-specific enzyme used as part of a chemotherapeutic regimen to treat patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. It works by depleting the stores of an important amino acid called asparagine, which is involved in DNA synthesis and cell survival of malignant cells, leading to cell death.
- Mechanism
- Curator reviewed · 4 references
Asparaginase Erwinia chrysanthemi is a tetrameric enzyme made up of four identical subunits, each having a molecular weight of about 35 kDa. It rapidly and completely catalyzes the deamidation reaction of L-asparagine to aspartic acid and ammonia, resulting in reduced levels of circulating asparagine in the plasma. Asparagine is essential for DNA synthesis, RNA synthesis, protein metabolism, and survival of leukemic cells; however, they lack the asparagine synthetase enzyme and depend on an exogenous source of asparagine. Asparaginase Erwinia chrysanthemi depletes the source of asparagine for leukemic cells, resulting in the death of leukemic cells. In addition to asparagine, asparaginase Erwinia chrysanthemi also deaminates glutamine to a lesser extent.
- Primary indication
- Asparaginase Erwinia chrysanthemi is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma in adults and children who have developed hypersensitivity to...Curator reviewed · 2 structured indications
- Formula / weight
- C1546H2510N432O476S9 · 140000.0 Da
- First approval
- Canada, 2016 · United States, 2011 · European Union, 2023
- Also known as
- Asparaginase (Erwinia chrysanthemi) · Asparaginase (Erwinia) · Asparaginase Erwinia chrysanthemi (recombinant) · asparaginase erwinia chrysanthemi (recombinant)-rywn · Crisantaspase
- Code names
- JZP-458 · PF743
- Brand names
- Enrylaze
- Erwinaze
- Rylaze
Resolves to
What you can answer from here — as of July 11, 2026
Which other approved drugs treat the same conditions as Asparaginase Erwinia chrysanthemi, and which companies have late-stage candidates in those indications?